CA2878481A1 - Method for preparing substituted triazolopyridines - Google Patents

Method for preparing substituted triazolopyridines Download PDF

Info

Publication number
CA2878481A1
CA2878481A1 CA2878481A CA2878481A CA2878481A1 CA 2878481 A1 CA2878481 A1 CA 2878481A1 CA 2878481 A CA2878481 A CA 2878481A CA 2878481 A CA2878481 A CA 2878481A CA 2878481 A1 CA2878481 A1 CA 2878481A1
Authority
CA
Canada
Prior art keywords
amino
phenyl
pyridin
triazolo
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2878481A
Other languages
English (en)
French (fr)
Inventor
Volker Schulze
Franz-Josef Mais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CA2878481A1 publication Critical patent/CA2878481A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2878481A 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines Abandoned CA2878481A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP12175640.7 2012-07-10
EP12175640 2012-07-10
EP12185590.2 2012-09-24
EP12185590 2012-09-24
EP13170585.7 2013-06-05
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
CA2878481A1 true CA2878481A1 (en) 2014-01-16

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2878481A Abandoned CA2878481A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Country Status (24)

Country Link
US (1) US9388177B2 (show.php)
EP (1) EP2872506A1 (show.php)
JP (1) JP6238979B2 (show.php)
KR (1) KR20150040845A (show.php)
CN (1) CN104603136B (show.php)
AP (1) AP3778A (show.php)
AU (1) AU2013289381A1 (show.php)
BR (1) BR112015000308A2 (show.php)
CA (1) CA2878481A1 (show.php)
CL (1) CL2015000038A1 (show.php)
CO (1) CO7160002A2 (show.php)
CR (1) CR20150006A (show.php)
DO (1) DOP2015000007A (show.php)
EA (1) EA027544B1 (show.php)
HK (1) HK1206731A1 (show.php)
IL (1) IL236265A (show.php)
IN (1) IN2015DN00085A (show.php)
MX (1) MX2015000348A (show.php)
NZ (1) NZ703020A (show.php)
PE (1) PE20150354A1 (show.php)
PH (1) PH12015500061A1 (show.php)
SG (1) SG11201408419QA (show.php)
TN (1) TN2015000008A1 (show.php)
WO (1) WO2014009219A1 (show.php)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195276A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
EA201600003A1 (ru) 2013-06-11 2016-06-30 Байер Фарма Акциенгезельшафт КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА
PT3008062T (pt) * 2013-06-11 2017-06-07 Bayer Pharma AG Derivados de profármaco de triazolopiridinas substituídas
CA2981844A1 (en) 2015-04-17 2016-10-20 Netherlands Translational Research Center B.V. Prognostic biomarkers for ttk inhibitor chemotherapy
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030937A1 (en) * 2001-10-05 2003-04-17 Ono Pharmaceutical Co., Ltd. Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
US20060074102A1 (en) * 2004-05-14 2006-04-06 Kevin Cusack Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
US7524860B2 (en) * 2004-10-07 2009-04-28 Pfizer Inc. Antibacterial agents
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
AR061229A1 (es) * 2006-06-06 2008-08-13 Schering Corp Imidazopirazinas como inhibidores de la proteina quinasa
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
CA2662074A1 (en) 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
AR067562A1 (es) 2007-07-18 2009-10-14 Novartis Ag Compuestos heterociclicos inhibidores de kinasa
WO2009024824A1 (en) 2007-08-23 2009-02-26 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
AU2008291075A1 (en) 2007-08-31 2009-03-05 Merck Serono S.A. Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
US20110212053A1 (en) * 2008-06-19 2011-09-01 Dapeng Qian Phosphatidylinositol 3 kinase inhibitors
JP2012517971A (ja) 2009-02-13 2012-08-09 フォーヴィア・ファーマシューティカルズ キナーゼ阻害薬としての[1,2,4]トリアゾロ[1,5−a]ピリジン類
CA2760077A1 (en) 2009-04-29 2010-11-04 Marcus Koppitz Substituted imidazoquinoxalines
CA2763900A1 (en) * 2009-06-05 2010-12-09 Cephalon, Inc. Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
CN102596932A (zh) 2009-09-04 2012-07-18 拜耳医药股份有限公司 作为酪氨酸苏氨酸激酶抑制剂的取代氨基喹喔啉
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
CN103608350B (zh) * 2011-04-21 2015-11-25 拜耳知识产权有限责任公司 三唑并吡啶类化合物
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
IN2015DN00085A (show.php) 2015-05-29
CL2015000038A1 (es) 2015-03-13
IL236265A0 (en) 2015-02-26
IL236265A (en) 2017-07-31
US20150148542A1 (en) 2015-05-28
BR112015000308A2 (pt) 2017-06-27
NZ703020A (en) 2017-08-25
JP6238979B2 (ja) 2017-11-29
JP2015523372A (ja) 2015-08-13
DOP2015000007A (es) 2015-02-15
US9388177B2 (en) 2016-07-12
SG11201408419QA (en) 2015-01-29
AU2013289381A1 (en) 2015-01-22
CN104603136B (zh) 2017-06-27
CR20150006A (es) 2015-02-16
PE20150354A1 (es) 2015-03-21
MX2015000348A (es) 2015-04-14
TN2015000008A1 (en) 2016-06-29
CO7160002A2 (es) 2015-01-15
EA201590116A1 (ru) 2015-07-30
HK1206731A1 (en) 2016-01-15
PH12015500061A1 (en) 2015-03-02
EA027544B1 (ru) 2017-08-31
EP2872506A1 (en) 2015-05-20
AP3778A (en) 2016-08-31
CN104603136A (zh) 2015-05-06
KR20150040845A (ko) 2015-04-15
AP2014008177A0 (en) 2014-12-31
WO2014009219A1 (en) 2014-01-16

Similar Documents

Publication Publication Date Title
TWI765908B (zh) 苯並咪唑類化合物激酶抑制劑及其製備方法和應用
JP5769199B2 (ja) ピラゾロピリミジンjak阻害剤化合物と方法
JP6564406B2 (ja) カゼインキナーゼ1デルタ/イプシロン阻害剤としてのイミダゾ−ピリダジン誘導体
CN103889962A (zh) 作为受体酪氨酸激酶btk抑制剂的取代的n-(3-(嘧啶-4-基)苯基)丙烯酰胺类似物
JP2019521996A (ja) キナーゼ阻害剤としてのn−(置換フェニル)−スルホンアミド誘導体
BR112014029708B1 (pt) Composto de pirrolo[2,1-f][1,2,4]triazina e método de preparação de compostos de pirrolo[2,1-f][1,2,4]triazina
KR20190058678A (ko) c-MET 억제제로서의 피리돈계 화합물
JP2023145548A (ja) Cd73阻害剤、その製造方法と応用
EA032642B1 (ru) АНАЛОГИ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K
CA2914668A1 (en) Novel compounds for the treatment of cancer
CA2878481A1 (en) Method for preparing substituted triazolopyridines
TW201900649A (zh) 一種氮雜芳基衍生物、其製備方法和在藥學上的應用
WO2023036156A1 (zh) Dna-pk选择性抑制剂及其制备方法和用途
CN112912142B (zh) 作为腺苷受体拮抗剂的5-氮杂吲唑衍生物
CA2914521A1 (en) Substituted triazolopyridines having activity as mps-1 inhibitors
CN105408332B (zh) 取代的三唑并吡啶类
CA2914745A1 (en) Prodrug derivatives of substituted triazolopyridines
HK1222652B (en) Substituted triazolopyridines

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190703